dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversity Health Network Princess Margaret Hospital Ontario Cancer Institute
dc.contributorUniversity of Toronto Department of Medical Biophysics
dc.contributorUniversity of Toronto Department of Laboratory Medicine and Pathobiology
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:17:25Z
dc.date.available2014-05-20T15:17:25Z
dc.date.created2014-05-20T15:17:25Z
dc.date.issued2003-01-01
dc.identifierGenetics and Molecular Biology. Sociedade Brasileira de Genética, v. 26, n. 2, p. 107-113, 2003.
dc.identifier1415-4757
dc.identifierhttp://hdl.handle.net/11449/30465
dc.identifier10.1590/S1415-47572003000200001
dc.identifierS1415-47572003000200001
dc.identifierS1415-47572003000200001.pdf
dc.identifier2259986546265579
dc.identifier6882035465809248
dc.description.abstractWe applied a combination of comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH), to characterize the genetic aberrations in three osteosarcomas (OS) and one Ewing's sarcoma. CGH identified recurrent chromosomal losses at 10p14-pter and gains at 8q22.3-24.1 in OS. Interphase FISH allowed to confirm 8q gain in two cases. A high amplification level of 11q12-qter was detected in one OS. The Ewing's sarcoma showed gain at 1p32-36.1 as the sole chromosome alteration. These studies demonstrate the value of molecular cytogenetic methods in the characterization of recurrent genomic alterations in bone tumor tissue.
dc.languageeng
dc.publisherSociedade Brasileira de Genética
dc.relationGenetics and Molecular Biology
dc.relation1.493
dc.relation0,638
dc.rightsAcesso aberto
dc.sourceSciELO
dc.subjectcomparative genomic hybridization
dc.subjectCGH
dc.subjectosteosarcoma
dc.subjectEwing's Sarcoma
dc.titleChromosomal imbalances detected in primary bone tumors by comparative genomic hybridization and interphase fluorescence in situ hybridization
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución